Use of heme oxygenase 1 inducers and cannabinoid 2 receptor or delta-opioid receptor agonists in inflammatory pain
申请人:Fundació Institut de Recerca de
l'Hospital de la Santa Creu l Sant Pau
公开号:EP2992880A1
公开(公告)日:2016-03-09
The present invention relates to a combination comprising at least an heme oxygenase 1 inducer, and at least a cannabinoid 2 receptor agonist or a selective δ-opioid receptor agonist, for use in the prevention and/or treatment of inflammatory pain.
本发明涉及一种组合物,至少包含一种血红素加氧酶 1 诱导剂和至少一种大麻素 2 受体激动剂或一种选择性 δ-阿片受体激动剂,用于预防和/或治疗炎症性疼痛。